Aenco is a Blockchain-based Healthcare financial solutions platform. Its main objective is to develop solutions for the HealthTech industry, such as institutional financing, prime brokerage, and smart capital solutions for the HealthTech industry. In addition, the Aenco platform aims to further research and collaborate with healthcare companies and projects that are integrated into the Blockchain development.
The AEN token is an Ethereum-based (ERC223) cryptocurrency developed by the Aenco. The token main objective is to become the “exclusive membership” token, designed to power the activities of the Aenco ecosystem, applications, and its HealthTech network.
Aenco (AEN) Coin Technology
Sorry, detailed technology about Aenco (AEN) is not currently available
Aenco (AEN) Coin Features
Sorry, detailed features about Aenco (AEN) is not currently available
Aenco ICO will begin on September 1, 2018. The ICO token supply represents 15% of the total token supply, so there is a total of 600,000,000 AEN tokens available, for 0.1 USD each. The ICO funding target is 15,000,000 USD, the funding cap is 60,000,000 USD and is expected to end on September 30, 2018 or when the funding cap is reached. Any unsold/remaining tokens beyond the Midcap shall be allocated to mining pool reserves.
Token Reserve Split (85%):
21% Retained by Company and Team;
15% Token Sale (excl. bonus allocations);
14% Bonus Allocations (on token sale) & Incentive Programs.
Aenco ICO campaign features bonus and the following bonus structure.
> 15 ETH 50%
> 5 ETH and ≤ 15 ETH 40%XX% WHEN;
≥ 1 ETH and ≤ 5 ETH 30%;
Week No. 1 - 15%;
Week No. 2 - 10%;
Week No. 3 - 5%;
Week No. 4 - 0%.
Read the Disclaimer: All content provided herein our website, hyperlinked sites, associated applications, forums, blogs, social media accounts and other platforms (“Site”) is for your general information only, procured from third party sources. We make no warranties of any kind in relation to our content, including but not limited to accuracy and updatedness. No part of the content that we provide constitutes financial advice, legal advice or any other form of advice meant for your specific reliance for any purpose. Any use or reliance on our content is solely at your own risk and discretion. You should conduct your own research, review, analyse and verify our content before relying on them. Trading is a highly risky activity that can lead to major losses, please therefore consult your financial advisor before making any decision. No content on our Site is meant to be a solicitation or offer